Fig. 8From: Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasisThe local response maintenance rate of GEF w/o RT group and control w/o RT group. The local response maintenance rate at 1 year was 92% and 54%, respectively (log-rank test p = 0.012). The median local response maintenance time in the GEF w/o RT group was 11.7 monthsBack to article page